These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 16737430)

  • 1. [Prevalence of hepatitis C virus among HIV-infected patients in Area 2 of Madrid].
    González Cerrajero M; Pazos García A; de los Santos Gil I; Sanz Sanz J
    An Med Interna; 2006 Mar; 23(3):111-4. PubMed ID: 16737430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroprevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) among human immunodeficiency virus (HIV)-infected patients in an HBV endemic area in Brazil.
    da Silva CM; de Peder LD; Guelere AM; Horvath JD; Silva ES; Teixeira JJV; Bertolini DA
    PLoS One; 2018; 13(9):e0203272. PubMed ID: 30192795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of hepatitis C in decentralised versus centralised drug substitution programmes and minimally invasive point-of-care tests to close gaps in the HCV cascade.
    Bregenzer A; Conen A; Knuchel J; Friedl A; Eigenmann F; Näf M; Ackle P; Roth M; Fux CA
    Swiss Med Wkly; 2017; 147():w14544. PubMed ID: 29185250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response predictors and clinical benefits of hepatitis C retreatment with pegylated interferon and ribavirin in HIV/HCV coinfection.
    Peribañez-Gonzalez M; da Silva MH; Vilar FC; Seixas-Santos Nastri AC; Ferreira PA; Focaccia R; Mendes Correa MC
    Ann Hepatol; 2013; 12(2):228-35. PubMed ID: 23396734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Risk behaviours and seroprevalence to HIV, HBV and HCV in patients of the AIDS information and prevention center in Valencia, Spain].
    Alfonso Gil R; Hurtado Navarro I; Espacio Casanovas A; Santos Rubio G; Tomás Dols S
    Gac Sanit; 1999; 13(1):16-21. PubMed ID: 10217673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus (HCV) treatment uptake and changes in the prevalence of HCV genotypes in HIV/HCV-coinfected patients.
    Medrano J; Resino S; Vispo E; Madejón A; Labarga P; Tuma P; Martín-Carbonero L; Barreiro P; Rodriguez-Novoa S; Jiménez-Nacher I; Soriano V
    J Viral Hepat; 2011 May; 18(5):325-30. PubMed ID: 20456635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of baseline CD4+ cell count and HIV-RNA on sustained virologic response to interferon-ribavirin in HIV/HCV coinfected patients.
    Aldámiz-Echevarría T; González-García J; Von Wichmann MA; Crespo M; López-Aldeguer J; Quereda C; Téllez MJ; Galindo MJ; Sanz J; Santos I; Guardiola JM; Bellón JM; Montes M; Berenguer J
    Ann Hepatol; 2015; 14(4):464-9. PubMed ID: 26019032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C prevalence in HIV-infected individuals: a comparison of inpatient and outpatient care.
    Zhu Z; Dhir T; Soe M; Green L; Jiang N
    Int J STD AIDS; 2014 Oct; 25(11):806-11. PubMed ID: 24492852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevalences of hepatitis virus coinfection and indications for chronic hepatitis C virus treatment and liver transplantation in Spanish HIV-infected patients. The GESIDA 29/02 and FIPSE 12185/01 Multicenter Study].
    González-García JJ; Mahillo B; Hernández S; Pacheco R; Diz S; García P; Esteban H; Arribas JR; Quereda C; Rubio R; Díez J; Moreno S; Vázquez-Rodríguez JJ
    Enferm Infecc Microbiol Clin; 2005; 23(6):340-8. PubMed ID: 15970166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutical aspects and outcome of HIV/HCV coinfected patients treated with pegylated interferon plus ribavirin in an Italian cohort.
    Righi E; Beltrame A; Bassetti M; Lindstrom V; Mazzarello G; Dentone C; Di Biagio A; Ratto S; Viscoli C
    Infection; 2008 Aug; 36(4):358-61. PubMed ID: 18642111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of HIV and hepatitis C virus infections among inmates of Ontario remand facilities.
    Calzavara L; Ramuscak N; Burchell AN; Swantee C; Myers T; Ford P; Fearon M; Raymond S
    CMAJ; 2007 Jul; 177(3):257-61. PubMed ID: 17664449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV and hepatitis C coinfection.
    Matthews GV; Dore GJ
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1000-8. PubMed ID: 18707597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of acute and chronic HCV infection in persons with HIV coinfection.
    Sulkowski MS
    J Hepatol; 2014 Nov; 61(1 Suppl):S108-19. PubMed ID: 25443339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low prevalence of hepatitis C co-infection in recently HIV-infected minority men who have sex with men in Los Angeles: a cross-sectional study.
    Chew KW; Blum ML; Javanbakht M; Clare LE; Bornfleth LD; Bolan R; Bhattacharya D; Gorbach PM
    BMC Infect Dis; 2015 Nov; 15():538. PubMed ID: 26590028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users.
    Roux P; Fugon L; Winnock M; Salmon-Céron D; Lacombe K; Sogni P; Spire B; Dabis F; Carrieri MP;
    Addiction; 2012 Jan; 107(1):152-9. PubMed ID: 21819472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of lymphoma in HIV-HCV-infected patients. Modifications in function of the anti-hepatitis C virus therapy.
    Gutiérrez-Saborido D; Gutiérrez-Valencia A; González Domenech CM; López Ruz MÁ; Raffo Márquez M; Omar M; Girón-González JA;
    Ann Hematol; 2019 Aug; 98(8):1953-1959. PubMed ID: 31025161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Proportion of HIV-HCV Coinfected Patients with Advanced Liver Fibrosis Requiring Hepatitis C Treatment in Haiphong, Northern Vietnam (ANRS 12262).
    Nguyen Truong T; Laureillard D; Lacombe K; Duong Thi H; Pham Thi Hanh P; Truong Thi Xuan L; Chu Thi N; Luong Que A; Vu Hai V; Nagot N; Tuaillon E; Dominguez S; Lemoine M
    PLoS One; 2016; 11(5):e0153744. PubMed ID: 27148964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current status of acute hepatitis C].
    Martínez-Rebollar M; Larrousse M; Calvo M; Muñoz A; González A; Loncà M; Martínez E; Blanco JL; Mallolas J; Laguno M
    Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):210-5. PubMed ID: 21334112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral lesions in HIV and HCV co-infected individuals in HAART era.
    Giuliani M; Lajolo C; Sartorio A; Ammassari A; Lacaita MG; Scivetti M; Tamburrini E; Tumbarello M
    J Oral Pathol Med; 2008 Sep; 37(8):468-74. PubMed ID: 18298476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross sectional study of factors associated to self-reported blood-borne infections among drug users.
    Reyes-Urueña J; Brugal MT; Majo X; Domingo-Salvany A; Caylà JA
    BMC Public Health; 2015 Nov; 15():1122. PubMed ID: 26566634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.